2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
3
Sponsor Class
OTHER
3
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
3
Other hematologic neoplasm
1
Gynecologic
1
Genitourinary
1
Conditions
Carcinoma, Hepatocellular
2
Neoplasms
1
Liver Neoplasms
1
Gastrointestinal Neoplasms
1
Interventions
Oxaliplatin
1439
Fluorouracil
1319
Capecitabine
1115
Gemcitabine
1058
Leucovorin
939
Bevacizumab
847
Irinotecan
830
Cisplatin
678
Radiotherapy
560
Cetuximab
482
pembrolizumab
437
Paclitaxel
401
Drug Therapy
358
Nivolumab
350
130-nm albumin-bound paclitaxel
329
Docetaxel
290
Sorafenib
288
S 1 (combination)
280
Folfox protocol
266
Albumin-Bound Paclitaxel
263
Surgical Procedures, Operative
258
lenvatinib
223
sintilimab
218
tislelizumab
214
durvalumab
212
regorafenib
209
Magnetic Resonance Spectroscopy
205
apatinib
204
Radiosurgery
204
Carboplatin
191
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Glutamyl Aminopeptidase
×
Gastrointestinal
×
Clear all
NCT05441163
2025-06-24
ProActIF-01
Institut Curie
Phase NA
Recruiting
50 enrolled
NCT05713994
2025-03-25
CCGLC-001
Tongji Hospital
Recruiting
300 enrolled
NCT05717738
2024-06-13
CCGLC-008
Tongji Hospital
Recruiting
300 enrolled